CLINICAL USE CASES FOR RMT
|
|
- Kerry Bennett
- 10 months ago
- Views:
Transcription
1 1 of 5 CLINICAL USE CASES FOR RMT USE CASE: WEANING FROM MECHANICAL VENTILATOR Benefits: Quicker time to ventilator liberation and trach decannulation A majority of LTAC patients are hard to wean from mechanical ventilator / ventilator dependent. Of those patients with COPD, 50% belong in this category. Prolonged mechanical ventilation leads to high resource utilization, increased complication and a tenfold higher rate of in-hospital mortality. A great application would be to use Breather to strengthen respiratory muscles to facilitate quicker time to ventilator liberation and trach decannulation. In patients who fail to wean from mechanical ventilation after surgery, RMT significantly increases the chance of successful liberation from 47% to 71% (1). Weaning success correlates with diaphragm thickness. RMT increases diaphragm thickness and reduces diaphragm asymmetry, contributing to weaning success (2). Research from LTAC specialty hospitals show that inspiratory muscle strength is an independent determinant of long- term survival of ventilator-weaned patients (3). Application of the Breather for the increase in respiratory muscle strength would therefore also greatly contribute to patient QOL and long-term survival.
2 USE CASE: CHRONIC LUNG DISEASE 2 of 5 Benefits: Less dyspnea, improved quality of life, shorter length of stay. In patients with chronic lung disease, respiratory muscle weakness contributes to dyspnea, reduced QOL, exercise intolerance, and higher morbidity and mortality. RMT through the use of The Breather will strengthen respiratory muscles to reduce dyspnea, improve QOL, mobility and exercise capacity, and lead to earlier discharges. In COPD patients, RMT improves respiratory muscle strength, and reduces dyspnea. This improves exercise capacity, QOL and activities of daily living (ADL) (4). Where aerobic exercise is possible, RMT improves the effects of exercise and pulmonary rehabilitation (5)(6). RMT improves hyperinflation, a clinical prognostic marker correlating with disease progression and outcome, thereby reducing the risk of death (7). In patients with COPD and asthma, RMT led to optimized drug delivery by inhalation, reducing the frequency of bronchodilator use (8)(9). In COPD patients, RMT reduces hospitalizations and healthcare requirements by 30% (10). USE CASE: DYSPHAGIA Benefits: Improved swallow function and airway clearance, reduced risk of pneumonia Dysphagia is prevalent in elderly people and those with COPD and other respiratory muscle disorders, and increases to at least 25% of LTAC patients without, and to up to 81% of those with neuromuscular disease such as stroke or Parkinson s. Dysphagia is associated with a 13% increase in mortality, mainly due to the increased risk of aspiration pneumonia. Patients with dysphagia have increased hospitalization rates and duration, and emergency department visits. In patients with Parkinson s, RMT improves swallow function by strengthening the suprahyoid muscle and reduces the aspiration rate (11)(12). USE CASE: CONGESTIVE HEART FAILURE Benefits: Improved symptoms and physiological causes of CHF Congestive heart failure has been declared as emerging epidemic, with a prevalence of 5.8 million in the US, rising annually, and an associated economic burden of $39 billion. CHF caused at least 550,000 hospitalizations per year, and 5- year survival rate lies at 50%. Risk factors for developing CHF include hypertension, obesity and smoking, and common comorbidities include COPD, asthma and other respiratory disorders, all contributing to the characteristic symptoms of dyspnea, exercise intolerance, and fatigue. Comorbidities also greatly contribute to the high readmission rate (69% within a year), as 68% of readmissions are non-chf mediated. RMT using the Breather has the potential to alleviate the symptoms of CHF, as well as to improve underlying causes such as hypertension, autonomic cardiac control and sympathetic nerve activity. Application is therefore effective in CHF patients and high-risk groups for developing CHF. RMT improves many clinical outcomes related to the pathophysiological manifestations of CHF including dyspnea, QOL, peripheral blood flow, sympathetic nervous system activity, heart rate, respiratory rate, ventilation, and exercise performance, as analyzed by a systematic literature review (13). Beyond, RMT effectively lowers blood pressure and reduces hypertension, helping to prevent CHF in high-risk patients (14).
3 3 of 5 Based on respiratory muscle weakness as a common denominator of CHF and many comorbidities, RMT provides a holistic therapeutic approach to the complex clinical syndrome of CHF. USE CASE: POSTOPERATIVE PULMONARY COMPLICATIONS Benefits: Reduction of PPC and length of hospital stay after major surgery Postoperative pulmonary complications such as pneumonia and atelectasis are the leading cause of morbidity and mortality after major cardiac or abdominal surgery. PPC increase the duration of hospitalization and healthcare costs. Preoperative RMT using the Breather reduce the risk of PPC, morbidity and mortality and decrease the length of stay. Preoperative RMT reduces PPC by 50% in patients undergoing coronary artery bypass graft surgery. RMT reduces postoperative pneumonia by 59% (15). Meta-analysis of pooled data confirms the effect of RMT to reduce postoperative pneumonia, atelectasis and duration of hospital stay (16). FINANCIAL IMPACT FROM ABOVE USE CASES BETTER PATIENT OUTCOMES Important patient outcomes in LTAC, especially for those patients with respiratory muscle weakness, include more effective rehabilitation and/or stabilization of disease, better quality of life, reduction of dyspnea, better mobility or exercise capacity, improvements in ADL, reduced risk of postoperative complications, and better speech and swallow function. Improvements of these outcomes reduces utilization of healthcare resources, ED visits and hospitalization rates. Research has documented that RMT significantly improves all of these patient outcomes across patient populations and different disorders, contributing to the reduction of the financial burden of LTAC patients. EXAMPLES PPCs after major surgery raise average costs by 30% from $20,430 to $26,683, amounting to a total added cost of $611 million per year. A reduction of PPC by 50% due to preoperative RMT is associated with potential savings of $305.5 million per year on a national level (17). Average cost of a dyspnea episode lies at $6958 per patient, and dyspnea is the reason for 3.7 million ED visits per year. The significant reduction of dyspnea caused by RMT across patient populations can be expected to reduce ED visits. A 10% reduction in ED visits translates to potential annual national savings of $2.57 billion (18)(19). SHORTER LENGTH OF STAY (LOS) Hospitalization represents the most important cost variable in the economic burden of long-term chronic disease. Reducing LOS significantly impacts on the financial burden of LTAC. EXAMPLES In COPD, hospitalization accounts for 45% to 50% of the total direct costs, which are estimated around $30 billion per year (20). RMT has been shown to reduce hospitalization by 30%, resulting in potential savings of $10 billion per year (10). Patients requiring prolonged mechanical ventilation account for more than 13% of ventilated patients and 37 % of
4 4 of 5 intensive care unit (ICU) costs nationally. The number of ICU patients transferred to LTACs for weaning is expected to increase substantially and will cost billions of dollars. The shorter weaning time of one technique over the other represents significant costs in terms of patients length of stay. Based on the stated number of 11,000 ventilator- dependent patients treated by Select each year and the average cost of on ICU day with ventilator of $5,666, reducing mechanical ventilation by just 1 day equals potential annual savings of $62,326,000. Preoperative RMT reduces PPC and can significantly reduce LOS. Based on published data following lung cancer surgery, postoperative LOS was reduced from 10.7 to 6.9 days. A 4-day reduction would indicate a cost saving of around $7512 per patient, based on average costs (21)(22). IMPROVED QUALITY OF LIFE QOL is an important patient outcome in LTAC. In chronic disease such as COPD, QOL directly correlates with disease severity, frequency of exacerbations, hospitalization, health care expenditure and mortality. Research among COPD patients has shown that patients with poorer QOL had higher direct medical costs (23). Improved QOL can therefore reduce disease severity, leading to reduced health care and resource utilization, directly alleviating the financial burden. Potential savings due to improved QOL can be defined by an increase in quality-adjusted life years (QALY). Financial impact of a plus in QALY can be seen by increased productivity of patient or carers, labor productivity gains where the working age population is concerned, and reduced health-care utilization. Utilities to determine the financial impact of QALY are disease-specific and have to be determined.
5 REFERENCES 5 of 5 1. Martin AD, et al. Inspiratory muscle strength training improves weaning outcome in failure to wean patients: a randomized trial. Crit Care. 2011;15(2):R Schellekens WJ, et al. Strategies to optimize respiratory muscle function in ICU patients. Crit Care. 2016;20(1): D.F. Dilling, et al. Determinants of Long term Survival in Patients Weaned from Prolonged Mechanical Ventilation R. Gosselink, J., et.al. Impact of inspiratory muscle training in patients with COPD. ERJ. 2011; 37(2): Elmorsi AS, et al. Effect of inspiratory muscle training on exercise performance and quality of life in patients with chronic obstructive pulmonary disease. Egypt J Chest Dis Tuberc. 2016;61(1): Magadle R Et al. Inspiratory muscle training in pulmonary rehabilitation program in COPD patients. Respir Med Jul;101(7): Petrovic M, et al. Effects of inspiratory muscle training on dynamic hyperinflation in patients with COPD. Int J Chron Obstruct Pulmon Dis 2012;7: Weiner P, et al. Inspiratory Muscle Training May Increase Peak Inspiratory Flow in Chronic Obstructive Pulmonary Disease. Respiration 2006;73: Leite Lima EVNC, et.al. Inspiratory muscle training and respiratory exercises in children with asthma. J Bras Pneumol. 2008;34(8): Beckerman M, et al. The Effects of 1 Year of Specific Inspiratory Muscle Training in Patients With COPD. CHEST 2005; 128: Pitts T, et al. Impact of expiratory muscle strength training on voluntary cough and swallow function in parkinson disease. Chest. 2009;135(5): Byeon H. Effect of simultaneous application of postural techniques and expiratory muscle strength training on the enhancement of the swallowing function of patients with dysphagia caused by parkinson's disease. J Phys Ther Sci. 2016;28(6): Cahalin LP, et al. Inspiratory muscle training in heart disease and heart failure: a review of the literature with a focus on method of training and outcomes. Expert Rev Cardiovasc Ther Feb;11(2): Ferreira JB, et al. Inspiratory muscle training reduces blood pressure and sympathetic activity in hypertensive patients: A randomized controlled trial. Int J Card 2013;166(1): Hulzebos EHJ, et al. Preoperative intensive inspiratory muscle training to prevent postoperative pulmonary complications in high-risk patients undergoing CABG surgery. JAMA 2006;296: Katsura M., et al. Preoperative inspiratory muscle training for postoperative pulmonary complications in adults undergoing cardiac and major abdominal surgery. Cochrane Database Syst Rev. 2015;(10):CD pulmonary-complications-following-common-abdominal-surgical-procedures/ 18. Bonafede M, et al. Impact of dyspnea on medical utilization and affiliated costs in patients with acute coronary syndrome. Hosp Pract. 2011;39(3): Guarascio AJ, et al. The clinical and economic burden of chronic obstructive pulmonary disease in the USA. Clinicoecon Outcomes Res. 2013;5: Lai Y, et al. Seven-day intensive preoperative rehabilitation for elderly patients with lung cancer: a randomized controlled trial. JSR 2017;209: Wu M, et al. Quality of life and its association with direct medical costs for COPD in urban China.Health Qual Life Outcomes. 2015;13:57.
American Thoracic Society (ATS) Perspective
National Surveillance System for Chronic Lung Disease (CLD): American Thoracic Society (ATS) Perspective Gerard J. Criner, M.D. Chronic Obstructive Pulmonary Disease (COPD) l Definition: Group of chronic
PROTOCOL BY USE CASE
PNMEDICAL PULMONARY AND SPEECH DEVICES THE BREATHER TM ONE DEVICE MANY THERAPIES PROTOCOL BY USE CASE Last Updated: 10/16/17 Version: 4.0 This guide was created to give you the general Breather protocol
THE CHALLENGES OF COPD MANAGEMENT IN PRIMARY CARE An Expert Roundtable
THE CHALLENGES OF COPD MANAGEMENT IN PRIMARY CARE An Expert Roundtable This activity is supported by an educational grant from Sunovion Pharmaceuticals Inc. COPD in the United States Third leading cause
Perioperative Pulmonary Management. Objectives
Citywide Resident Perioperative Medical Consult Conference Perioperative Pulmonary Management Frank Jacono, MD May 5, 2017 Objectives Definition of post-operative pulmonary complications (PPC) Risk factors
Nasal High Flow Humidification with or without Oxygen for COPD Management. Shereen Bailey, RCP, RRT, NPS
Nasal High Flow Humidification with or without Oxygen for COPD Management Shereen Bailey, RCP, RRT, NPS Objectives How it works COPD Management today The role of NHFC Evidence Research/Case Studies Types
Fact Sheet. VitalStim Therapy
VitalStim Therapy Fact Sheet Dysphagia, or difficulty with swallowing, is a sorely neglected medical disorder that impacts as many as 15 million Americans, with approximately one million people annually
A Place For Airway Clearance Therapy In Today s Healthcare Environment
A Place For Airway Clearance Therapy In Today s Healthcare Environment Michigan Society for Respiratory Care 2015 Fall Conference K. James Ehlen, MD October 6, 2015 Objectives Describe patients who will
Fariba Rezaeetalab Associate Professor,Pulmonologist
Fariba Rezaeetalab Associate Professor,Pulmonologist rezaitalabf@mums.ac.ir Patient related risk factors Procedure related risk factors Preoperative risk assessment Risk reduction strategies Age Obesity
Mechanical Ventilation of the Patient with Neuromuscular Disease
Mechanical Ventilation of the Patient with Neuromuscular Disease Dean Hess PhD RRT Associate Professor of Anesthesia, Harvard Medical School Assistant Director of Respiratory Care, Massachusetts General
The MetaNeb System Three therapies. One device. An effective and efficient solution.
The MetaNeb System Three therapies. One device. An effective and efficient solution. Three therapies. One device. An effective and efficient solution. The MetaNeb System is designed to mobilize retained
How to limit avoidable disability
How to limit avoidable disability Associate professor Susanne S Hernes Sept.22. 2017 Add the logo of your institution here CONFLICT OF INTEREST DISCLOSURE I have no potential conflicts of interest to report
THE POTENTIAL IMPACT OF VITALSTIM THERAPY ON HEALTHCARE COSTS: A White PaperVitalStim Therapy has significant
Dysphagia THE POTENTIAL IMPACT OF VITALSTIM THERAPY ON HEALTHCARE COSTS: A White PaperVitalStim Therapy has significant Contents potential to dramatically impact the health care costs arising from oropharyngeal
Noninvasive Ventilation: Non-COPD Applications
Noninvasive Ventilation: Non-COPD Applications NONINVASIVE MECHANICAL VENTILATION Why Noninvasive Ventilation? Avoids upper A respiratory airway trauma system lacerations, protective hemorrhage strategy
Chronic Obstructive Pulmonary Disease (COPD) Clinical Guideline
Chronic Obstructive Pulmonary Disease (COPD) Clinical These clinical guidelines are designed to assist clinicians by providing an analytical framework for the evaluation and treatment of patients. They
Interventional procedures guidance Published: 20 December 2017 nice.org.uk/guidance/ipg600
Endobronchial valve insertion to reduce lung volume in emphysema Interventional procedures guidance Published: 20 December 2017 nice.org.uk/guidance/ipg600 Your responsibility This guidance represents
Pulmonary Rehabilitation
Pulmonary Rehabilitation What do these patients have in common? Factors contributing to exercise intolerance Factors contributing to exercise intolerance Factors contributing to exercise intolerance Factors
PULMONARY REHABILITATION Current Evidence and Recommendations
PULMONARY REHABILITATION Current Evidence and Recommendations Overview Introduction to Pulmonary Rehabilitation Pathophysiolgy of Exercise Limitation Exercise training Current evidence for COPD Current
How to Address an Inappropriately high Mortality Rate? Joe Sharma, MD Associate Professor of Surgery NSQIP Surgical Champion
How to Address an Inappropriately high Mortality Rate? Joe Sharma, MD Associate Professor of Surgery NSQIP Surgical Champion Disclosure Slide No COI and no disclosures. Hospital Mortality rate : is it
Over the last several years various national and
Recommendations for the Management of COPD* Gary T. Ferguson, MD, FCCP Three sets of guidelines for the management of COPD that are widely recognized (from the European Respiratory Society [ERS], American
Recent Advances in Respiratory Medicine
Recent Advances in Respiratory Medicine Dr. R KUMAR Pulmonologist Non Invasive Ventilation (NIV) NIV Noninvasive ventilation (NIV) refers to the administration of ventilatory support without using an invasive
Sample Case Study. The patient was a 77-year-old female who arrived to the emergency room on
Sample Case Study The patient was a 77-year-old female who arrived to the emergency room on February 25 th with a chief complaint of shortness of breath and a deteriorating pulmonary status along with
Haemodynamic and Respiratory Responses to Abdominal Muscle FES A Pilot Study
Haemodynamic and Respiratory Responses to Abdominal Muscle FES A Pilot Study H Rischbieth 1 *, J Clark 1, S Donohoe 1, J Strayer 1,2, M Jelbart 1, K Stiller 3, T McDonald 3, R Marshall 1,2. FES Clinic,
Pulmonary Function Testing The Basics of Interpretation
Pulmonary Function Testing The Basics of Interpretation Jennifer Hale, M.D. Valley Baptist Family Practice Residency Objectives Identify the components of PFTs Describe the indications Develop a stepwise
Medicare and Medicaid Payments
and Payments The following table includes information about payments made by and for the 17 medical conditions/surgical procedures included in this Hospital Performance Report. This analysis is based on
PERIOPERATIVE ANESTHETIC RISK IN THE GERIATRIC PATIENT
PERIOPERATIVE ANESTHETIC RISK IN THE GERIATRIC PATIENT Susan H. Noorily, M.D. Clinical Professor of Anesthesiology Medical Director University Preoperative Medicine Center IMPORTANCE Half of all currently
OHTAC Recommendation: Chronic Obstructive Pulmonary Disease (COPD) Ontario Health Technology Advisory Committee
OHTAC Recommendation: Chronic Obstructive Pulmonary Disease (COPD) Ontario Health Technology Advisory Committee March 2012 Background The Chronic Obstructive Pulmonary Disease Mega-Analysis series is made
AECOPD: Management and Prevention
Neil MacIntyre MD Duke University Medical Center Durham NC Professor P.J. Barnes, MD, National Heart and Lung Institute, London UK Professor Peter J. Barnes, MD National Heart and Lung Institute, London
What is the next best step?
Noninvasive Ventilation William Janssen, M.D. Assistant Professor of Medicine National Jewish Health University of Colorado Denver Health Sciences Center What is the next best step? 65 year old female
Prophylactic respiratory physiotherapy after cardiac surgery
Prophylactic respiratory physiotherapy after cardiac surgery Patrick Pasquina; Martin R Tramèr, MD, D. Phil; Bernhard Walder, MD Divisions of Surgical Intensive Care (Mr Pasquina) and Anaesthesia (Drs
Performance Measure Name: TOB-3 Tobacco Use Treatment Provided or Offered at Discharge TOB-3a Tobacco Use Treatment at Discharge
Measure Information Form Collected For: The Joint Commission Only CMS Informational Only Measure Set: Tobacco Treatment (TOB) Set Measure ID #: Last Updated: New Measure Version 4.0 Performance Measure
A New Look at Managing Chronic Obstructive Pulmonary Disease (COPD): NIV Therapy
A New Look at Managing Chronic Obstructive Pulmonary Disease (COPD): NIV Therapy 1 ResMed 2013 Global leaders in sleep and respiratory medicine COPD Market Size Over 12M people in the US diagnosed with
ROBERTO P. BENZO, MD, MS
COPD PHENOTYPES ROBERTO P. BENZO, MD, MS DIRECTOR, MINDFUL BREATHING LABORATORY MAYO CLINIC ROCHESTER, MN Dr. Benzo is the founding director of the Breathing and Behavior Laboratory, which develops and
The links between physical health in mental health
The links between physical health in mental health A holistic approach to managing mental and physical health is needed. Physical and mental health are inextricably linked 1 What is the problem? It is
Quality ID#164 (NQF 0129): Coronary Artery Bypass Graft (CABG): Prolonged Intubation National Quality Strategy Domain: Effective Clincial Care
Quality ID#164 (NQF 0129): Coronary Artery Bypass Graft (CABG): Prolonged Intubation National Quality Strategy Domain: Effective Clincial Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE
COPD: early detection, screening and case-finding: what is the evidence? Prof. Jan-Willem Lammers, Md PhD Department of Respiratory Diseases
COPD: early detection, screening and case-finding: what is the evidence? Prof. Jan-Willem Lammers, Md PhD Department of Respiratory Diseases «If you test one smoker with cough every day You will diagnose
Optimizing the Lung Transplant Candidate through Exercise Training. Lisa Wickerson BScPT, MSc Canadian Respiratory Conference April 25, 2014
Optimizing the Lung Transplant Candidate through Exercise Training Lisa Wickerson BScPT, MSc Canadian Respiratory Conference April 25, 2014 Conflicts of Interest None to declare Learning Objectives At
Chapter 10 Respiratory System J00-J99. Presented by: Jesicca Andrews
Chapter 10 Respiratory System J00-J99 Presented by: Jesicca Andrews 1 Respiratory System 2 Respiratory Infections A respiratory infection cannot be assumed from a laboratory report alone; physician concurrence
Best of Pulmonary Jennifer R. Hucks, MD University of South Carolina School of Medicine
Best of Pulmonary 2012-2013 Jennifer R. Hucks, MD University of South Carolina School of Medicine Topics ARDS- Berlin Definition Prone Positioning For ARDS Lung Protective Ventilation In Patients Without
Transfusion & Mortality. Philippe Van der Linden MD, PhD
Transfusion & Mortality Philippe Van der Linden MD, PhD Conflict of Interest Disclosure In the past 5 years, I have received honoraria or travel support for consulting or lecturing from the following companies:
Dyspnea. Stephanie Lindsay
Dyspnea Stephanie Lindsay What is dyspnea? An unpleasant sensation of difficult, labored breathing Shortness of air Dyspnea is not the same as tachypnea therefore patients may not present with rapid breathing
National Asthma Educator Certification Board Detailed Content Outline
I. THE ASTHMA CONDITION 9 20 1 30 A. Pathophysiology 4 6 0 10 1. Teach an individual with asthma and their family using simple language by illustrating the following with appropriate educational aids a.
Home Pulse Oximetry for Infants and Children
Last Review Date: April 21, 2017 Number: MG.MM.DM.12aC2v2 Medical Guideline Disclaimer Property of EmblemHealth. All rights reserved. The treating physician or primary care provider must submit to EmblemHealth
Chronic obstructive lung disease. Dr/Rehab F.Gwada
Chronic obstructive lung disease Dr/Rehab F.Gwada Obstructive lung diseases Problem is in the expiratory phase Lung disease Restrictive lung disease Restriction may be with, or within the chest wall Problem
The objectives of this presentation are to
1 The objectives of this presentation are to 1. Review the mechanics of airway clearance 2. Understand the difference between secretion mobilization and secretion clearance 3. Identify conditions that
The Role of Information Technology in Disease Management: A Case for Heart Failure
The Role of Information Technology in Disease Management: A Case for Heart Failure Teresa De Peralta, MSN, APN-C Heart Failure Product Workflow Consultant Medtronic Population Management Level 3: As patient
Airway Clearance. Outcome Measures in Airway Clearance. Secretion Retention. Retained Secretions is Undesirable 03/04/2013
Outcome Measures in Airway Clearance Dean R. Hess PhD RRT Assistant Director of Respiratory Care Massachusetts General Hospital Associate Professor of Anesthesia Harvard Medical School Editor in Chief
DIAGRAM OF THE PRESENTATION. Post ICU Rehabilitation. Effective strategies in ICU. During two last decades
1 1st European Conference on Weaning & Rehabilitation in Critically ill Patients INTERNATIONAL EARLY MOBILISATION NETWORK Post ICU Rehabilitation Serafeim N. Nanas Professor of Critical Care Medicine Evaggelismos
Effects of Physical Activity and Sleep Quality in Prevention of Asthma
Journal of Physiology and Pharmacology Advances Effects of Physical Activity and Sleep Quality in Prevention of Asthma Tartibian B., Yaghoobnezhad F. and Abdollahzadeh N. J Phys Pharm Adv 2014, 4(5): 356-359
5/3/2012 PRESENTATION GOALS RESPIRATORY THERAPISTS ROLE IN END OF LIFE CARE FOR THE PULMONARY PATIENT
RESPIRATORY THERAPISTS ROLE IN END OF LIFE CARE FOR THE PULMONARY PATIENT Presented by Carrie Black Bourassa, LRT, RRT PRESENTATION GOALS Define palliative care Define hospice care Discuss pulmonary hospice
Anatomy & Physiology 2 Canale. Respiratory System: Exchange of Gases
Anatomy & Physiology 2 Canale Respiratory System: Exchange of Gases Why is it so hard to hold your breath for Discuss! : ) a long time? Every year carbon monoxide poisoning kills 500 people and sends another
To Correlate Ejection Fraction with 6 Minute Walked Distance and Quality of Life in Patients with Left Ventricular Heart Failure
To Correlate Ejection Fraction with 6 Minute Walked Distance and Quality of Life in Patients with Left Ventricular Heart Failure Pramila S Kudtarkar*, Mariya P Jiandani*, Ashish Nabar** Abstract Purpose
Survey on Chronic Respiratory Diseases at the PrimaryHealth Care Level
Survey on Chronic Respiratory Diseases at the PrimaryHealth Care Level Nikolai Khaltaev MD, PhD GARD General Meeting Istanbul, Turkey, 30-31 May 2008 Burden of major respiratory diseases Respiratory diseases
Management of Acute Exacerbations
15 Management of Acute Exacerbations Cenk Kirakli Izmir Dr. Suat Seren Chest Diseases and Surgery Training Hospital Turkey 1. Introduction American Thoracic Society (ATS) and European Respiratory Society
VitaBreath. Helping your COPD patients remain active
VitaBreath Helping your COPD patients remain active COPD: A chronic condition to manage Chronic Obstructive Pulmonary Disease (COPD) is a chronic disorder characterised by consistent airflow obstruction
Noninvasive ventilation: Selection of patient, interfaces, initiation and weaning
CME article Johnson S, et al: Noninvasive ventilation Noninvasive ventilation: Selection of patient, interfaces, initiation and weaning Saumy Johnson, Ramesh Unnikrishnan * Email: ramesh.unnikrishnan@manipal.edu
Pulmonary Rehabilitation in COPD-An Important Non-pharmacological Treatment
122 Review Article Pulmonary Rehabilitation in COPD-An Important Non-pharmacological Treatment Department of Adult Nursing, Maharajgunj Nursing Campus, Institute of Medicine, Tribhuvan University, Kathmandu,
COMMISSION ON ACCREDITATION FOR RESPIRATORY CARE TMC DETAILED CONTENT OUTLINE COMPARISON
A. Evaluate Data in the Patient Record I. PATIENT DATA EVALUATION AND RECOMMENDATIONS 1. Patient history e.g., admission data orders medications progress notes DNR status / advance directives social history
Rubine de Beer Physiotherapist. Steve Biko Academic Hospital February 2014
Rubine de Beer Physiotherapist Steve Biko Academic Hospital February 2014 Mobilisation Asher 1947 Teach us to live that we may dread unnecessary time in bed. Get people up and we may save our patients
UNDERSTANDING COPD MEDIA BACKGROUNDER
UNDERSTANDING COPD MEDIA BACKGROUNDER What is COPD? Chronic Obstructive Pulmonary Disease (COPD) also called emphysema and/or chronic obstructive bronchitis* is a preventable lung disease caused by the
Public Dissemination
1. THE ASTHMA CONDITION 9 18 3 30 A. Pathophysiology 4 6 0 10 1. Teach an individual with asthma and their family using simple language by illustrating the following with appropriate educational aids a.
05/11/2016. Riabilitazione cardiorespiratoria nell anziano INTERNATIONAL GUIDELINES: INDICATIONS FOR REHABILITATION
Università degli Studi di Salerno CARDIOVASCULAR AND RESPIRATORY DISEASES ARE THE LEADING CAUSES OF DEATH Riabilitazione cardiorespiratoria nell anziano Cardiopulmonary rehabilitation in elderly Amelia
COPD and Asthma Update. April 29 th, 2017 Rachel M Taliercio, DO Staff, Respiratory Institute
COPD and Asthma Update April 29 th, 2017 Rachel M Taliercio, DO Staff, Respiratory Institute What we ll be talking about COPD: diagnosis, management of stable COPD, COPD exacerbations Asthma: diagnosis,
Overview of COPD INTRODUCTION
Overview of COPD INTRODUCTION Chronic obstructive pulmonary disease (COPD) is a common lung disease that affects millions of people, and it is the fourth leading cause of death in the United States. It
Outcomes for Critically Ill Sepsis Survivors
Outcomes for Critically Ill Sepsis Survivors Yasmine Ali Abdelhamid Discipline of Acute Care Medicine, University of Adelaide Intensive Care Unit, Royal Adelaide Hospital Adelaide, South Australia Sepsis
Disclosures. Chronic Obstructive Pulmonary Disease. Chronic Obstructive Pulmonary Disease (COPD)
Chronic Obstructive Pulmonary Disease May 14, 2016 Orlando, FL COPD (Chronic obstructive pulmonary disease) is a major cause of mortality and morbidity in the United States. Alarmingly, COPD recently became
Beyond the Next Breath: Controlling Costs and Maximizing COPD Outcomes
Beyond the Next Breath: Controlling Costs and Maximizing COPD Outcomes Edith Haage, PT, GCS NewCourtland Senior Services 10/21/2015 NEWCOURTLAND.org 1-888-530-4913 http://www.poliosurvivorsnetwork.org.uk/archive/lincolnshire/library/australia/paleop/ima
ResMed Inc. 36 th Annual J.P. Morgan Healthcare Conference
ResMed Inc. 36 th Annual J.P. Morgan Healthcare Conference Mick Farrell CEO January 8, 2018 Safe Harbor Statement Statements contained in this presentation that are not historical facts are forwardlooking
Comorbidities in HF COPD Chronic Obstructive Pulmonary Disease Gerasimos Filippatos Athens, Greece
Comorbidities in HF COPD Chronic Obstructive Pulmonary Disease Gerasimos Filippatos Athens, Greece Epidemiology of heart failure in chronic obstructive pulmonary disease (COPD) patients and vice versa.
Coexistence of confirmed obstruction in spirometry and restriction in body plethysmography, e.g.: COPD + pulmonary fibrosis
Volumes: IRV inspiratory reserve volume Vt tidal volume ERV expiratory reserve volume RV residual volume Marcin Grabicki Department of Pulmonology, Allergology and Respiratory Oncology Poznań University
PULMONARY FUNCTION. VOLUMES AND CAPACITIES
PULMONARY FUNCTION. VOLUMES AND CAPACITIES The volume of air a person inhales (inspires) and exhales (expires) can be measured with a spirometer (spiro = breath, meter = to measure). A bell spirometer
Pulmonary and Critical Care
Pulmonary and Critical Care 2015-2016 DRAFT REPORT FOR COMMENT April 21, 2016 This report is funded by the Department of Health and Human Services under contract HHSM-500-2012-00009I Task Order HHSM-500-T0000
JOINT CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) MANAGEMENT GUIDELINES
JOINT CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) MANAGEMENT GUIDELINES Authors Dr Ian Benton Respiratory Consultant COCH Penny Rideal Respiratory Nurse COCH Kirti Burgul Respiratory Pharmacist COCH Pam
HREVS: A Randomized Trial of PCI vs CABG vs Hybrid Revascularization in Patients With Coronary Artery Disease. Vladimir Ganyukov, MD, PhD
HREVS: A Randomized Trial of PCI vs CABG vs Hybrid Revascularization in Patients With Coronary Artery Disease Vladimir Ganyukov, MD, PhD Nikita Kochergin MD, Aleksandr Shilov MD, PhD, Roman Tarasov, MD,
RESPIRATORY FAILURE NON INVASIVE VENTILATION TREATMENT
RESPIRATORY FAILURE NON INVASIVE VENTILATION TREATMENT Dr. Dhruva Chaudhry Senior Professor & Chair Pulmonary & Critical Care Medicine PGIMS,UHS Rohtak, Haryana General Secretary (Elect) Indian Society
Exacerbations. Ronald Dahl, Aarhus University Hospital, Denmark
1st WAO Allied Health Session - Asthma: Diagnosi Exacerbations Ronald Dahl, Aarhus University Hospital, Denmark The health professional that care for patients with asthma exacerbation must be able to Identificafy
Choosing an inhaler for COPD made simple. Dr Simon Hart Castle Hill Hospital
Choosing an inhaler for COPD made simple Dr Simon Hart Castle Hill Hospital 1 Declaration of interests I have received speaker fees, sponsorship to attend conferences, and funding for research from companies
QOF indicator area: Chronic Obstructive Pulmonary disease (COPD)
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE QUALITY AND OUTCOMES FRAMEWORK (QOF) INDICATOR DEVELOPMENT PROGRAMME Cost impact statement: Chronic Obstructive Pulmonary Disease QOF indicator area:
Lung Volume Reduction Surgery. February 2013
Lung Volume Reduction Surgery February 2013 Presentation Outline Lung Volume Reduction Surgery (LVRS) Rationale & Historical Perspective NETT Results Current LVRS Process (from referral to surgery) Diagnostic
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE SCOPE
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE 1 Guideline title SCOPE Bronchiolitis: diagnosis and management of bronchiolitis in children. 1.1 Short title Bronchiolitis in children 2 The remit The
Pulmonary Rehabilitation
Pulmonary Rehabilitation Date of Origin: 06/2005 Last Review Date: 10/25/2017 Effective Date: 10/25/2017 Dates Reviewed: 05/2006, 05/2007, 05/2008, 11/2009, 02/2011, 01/2012, 08/2013, 07/2014, 09/2015,
Cardiac & Pulmonary Rehab Individual Treatment Plan
Initial Assessment Date: Re-Assessment Date: Re-Assessment Date: Follow-Up Discharge Date: Risk Assessment Risk Assessment Risk Assessment Risk Assessment BP SpO2 BP SpO2 BP SpO2 BP SpO2 HR Edema HR Edema
The Geriatrician in the Trauma Service. Trauma Quality Improvement Program (TQIP) Annual Scientific Meeting and Training 2013
The Geriatrician in the Trauma Service Trauma Quality Improvement Program (TQIP) Annual Scientific Meeting and Training 2013 Challenges of the Geriatric Trauma Patient Challenges of the Geriatric Patient
Hyperinflation Therapy and the Tools to Accomplish It!! Bill Barnes, RN, RRT Good Shepherd Rehabilitation Network
Hyperinflation Therapy and the Tools to Accomplish It!! Bill Barnes, RN, RRT Good Shepherd Rehabilitation Network HYPERINFLATION THERAPY Challenges in Post Acute Care Deconditioning Malnutrition Hydration
Effects of Smoking and Cessation on Physiology and Perioperative Outcomes
TOBACCO CESSATION FOR SURGICAL PATIENTS David O. Warner, M.D. Department of Anesthesiology Mayo Clinic Rochester warner.david@mayo.edu Introduction The public health consequences of cigarette smoking are
IJPHY ABSTRACT. Int J Physiother. Vol 3(1), , February (2016) ISSN: ORIGINAL ARTICLE /ijphy/2016/v3i1/88929
Int J Physiother. Vol 3(1), 140-146, February (2016) ISSN: 2348-8336 ORIGINAL ARTICLE IJPHY ABSTRACT COMPARATIVE STUDY ON THE IMMEDIATE EFFECTS OF DEEP BREATHING EXERCISES WITH PEP DEVICE VERSES IN- CENTIVE
CHF Exercise Tutorial
CHF Exercise Tutorial This template can be accessed from: AAA Home 1 of 9 LESS Initiative 2 of 9 Main Tool Bar When the Template button is clicked you will be presented with the preference list. If the
HQID Hospital Performance Update & Analysis of Quality, Cost and Mortality Trends Fact Sheet
HQID Hospital Performance Update & Analysis of Quality, Cost and Mortality Trends Fact Sheet I.) Performance of Hospitals in the Hospital Quality Incentive Demonstration over 15 Quarters* (pages 2-5) Launched
Preoperative Workup for Pulmonary Resection. Kristen Bridges, M.D. Richmond University Medical Center January 21, 2016
Preoperative Workup for Pulmonary Resection Kristen Bridges, M.D. Richmond University Medical Center January 21, 2016 Patient Presentation 50 yo male with 70 pack year smoking history Large R hilar lung
DIAGNOSTIC NOTE TEMPLATE
DIAGNOSTIC NOTE TEMPLATE SOAP NOTE TEMPLATE WHEN CONSIDERING A DIAGNOSIS OF IDIOPATHIC PULMONARY FIBROSIS (IPF) CHIEF COMPLAINT HISTORY OF PRESENT ILLNESS Consider IPF as possible diagnosis if any of the
Sedation Management AfteR Tracheostomy (SMART) study
Sedation Management AfteR Tracheostomy (SMART) study Koji Hosokawa, MD 1 Egi M., MD 2, Nishimura M., MD 3 1 Kyoto Prefectural Yosanoumi Hospital, Kyoto, Japan 2 Okayama, Japan, 3 Tokushima, Japan ANZICS
DATE: 09 December 2009 CONTEXT AND POLICY ISSUES:
TITLE: Tiotropium Compared with Ipratropium for Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease: A Review of the Clinical Effectiveness DATE: 09 December 2009 CONTEXT AND POLICY
BTS/ICS Guidelines for the ventilatory management of acute hypercapnic respiratory failure in adults
BTS/ICS Guidelines for the ventilatory management of acute hypercapnic respiratory failure in adults British Thoracic Society Intensive Care Society Introduction Acute Hypercapnic Respiratory Failure (AHRF)
EXACERBATION ASSESSMENT FORM
EXACERBATION ASSESSMENT FORM ID NUMBER: 0a) Form Completion Date... 0b) Staff Code... Administrative Information 1) Date of clinic visit: 2) What type of Event is this?... Participant/HCU-triggered...
Cardiopulmonary Stress Testing: Beyond Transplant Evaluation
Cardiopulmonary Stress Testing: Beyond Transplant Evaluation Ross Arena, PhD, PT, FAHA, FESC, FACSM Professor and Head College of Applied Health Sciences University of Illinois at Chicago Cardio- Pulmonary
Prolonged Mechanical Ventilation
Prolonged Mechanical Ventilation Shannon S. Carson, MD Associate Professor and Chief Pulmonary and Critical Care Medicine University of North Carolina AJRCCM 2010 Projected Growth of Prolonged Acute MV